semaglutide patent expiry india With semaglutide's expiring, generics are set to enter from soon, setting off competition in a fast-growing segment of obesity and diabetes care. https://timesofindia.indiatimes.com/toi-plus/business-economy/why-miracle-weight-loss-drugs-are India's Semaglutide Patent Expiry Sparks

This article examines the evidence, potential risks, and alternative options for individuals with inflammatory bowel disease considering Ozempic, emphasising the importance of individualised assessment and multidisciplinary care involving both gastroenterology and diabetes specialists

Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells

Browse Products Metabolic Research Program Tirzepatide is a dual GIP/GLP-1 receptor agonist investigated in metabolic research for its effects on insulin sensitivity and energy balance

Anti-Taches Pigmentaires

Disclaimer: Comprehensive human safety data for these peptides are limited